Omni Partners US’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	$3.83M	Buy	383,033 +18,662	+5%	+$187K	0.2%	96
2021 Q2	$3.66M	Buy	+364,371	New	+$3.66M	0.16%	63